New drug BL0175 tested for safety in postmenopausal women
NCT ID NCT07366632
First seen Jan 31, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This early-stage trial tests a single dose of the experimental drug BL0175 in 27 postmenopausal women to see what side effects occur and how long the drug stays in the body. It compares BL0175 to the existing drug fulvestrant. The study does not aim to treat any disease, only to gather safety and drug-level information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.